Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

119
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
119
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

1.3K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.3K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

699
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
699
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

523
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
523
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Despite Big Buildup, Few Benefit From Medicare's Advance Care Planning Coverage.

JAMA·2021
Same author

The Push for Earlier Bariatric Surgery for Adolescents With Severe Obesity.

JAMA·2021
Same author

Trends Identified in Foodborne Illnesses From Leafy Greens.

JAMA·2021
Same author

Point-of-Care Test for Sexually Transmitted Infections.

JAMA·2021
Same author

Reprocessed Urological Endoscopes Tied to Infection Risk.

JAMA·2021
Same author

Start-ups Tout Continuous Glucose Monitoring for People Without Diabetes.

JAMA·2021

Video Experimental Relacionado

Updated: Dec 14, 2025

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
11:51

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

31.2K

Segundo medicamento aprobado para enfermedades raras del sistema nervioso central

Mary Chris Jaklevic

    JAMA
    |July 22, 2020
    PubMed
    Resumen

    No abstract available in PubMed .

    Más Videos Relacionados

    Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
    07:47

    Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

    Published on: October 29, 2019

    19.4K
    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
    14:55

    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

    Published on: May 12, 2013

    61.5K

    Videos de Experimentos Relacionados

    Last Updated: Dec 14, 2025

    Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
    11:51

    Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

    Published on: August 16, 2010

    31.2K
    Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
    07:47

    Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

    Published on: October 29, 2019

    19.4K
    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
    14:55

    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

    Published on: May 12, 2013

    61.5K